211 related articles for article (PubMed ID: 19431193)
1. IL1B polymorphisms modulate cystic fibrosis lung disease.
Levy H; Murphy A; Zou F; Gerard C; Klanderman B; Schuemann B; Lazarus R; García KC; Celedón JC; Drumm M; Dahmer M; Quasney M; Schneck K; Reske M; Knowles MR; Pier GB; Lange C; Weiss ST
Pediatr Pulmonol; 2009 Jun; 44(6):580-93. PubMed ID: 19431193
[TBL] [Abstract][Full Text] [Related]
2. Genetic modifiers of lung disease in cystic fibrosis.
Drumm ML; Konstan MW; Schluchter MD; Handler A; Pace R; Zou F; Zariwala M; Fargo D; Xu A; Dunn JM; Darrah RJ; Dorfman R; Sandford AJ; Corey M; Zielenski J; Durie P; Goddard K; Yankaskas JR; Wright FA; Knowles MR;
N Engl J Med; 2005 Oct; 353(14):1443-53. PubMed ID: 16207846
[TBL] [Abstract][Full Text] [Related]
3. Analysis of DEFB1 regulatory SNPs in cystic fibrosis patients from North-Eastern Italy.
Segat L; Morgutti M; Athanasakis E; Trevisiol C; Amaddeo A; Poli F; Crovella S
Int J Immunogenet; 2010 Jun; 37(3):169-75. PubMed ID: 20193032
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.
Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB
Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926
[TBL] [Abstract][Full Text] [Related]
5. Influence of SNPs in Genes that Modulate Lung Disease Severity in a Group of Mexican Patients with Cystic Fibrosis.
Yokoyama E; Chávez-Saldaña M; Orozco L; Cuevas F; Lezana JL; Vigueras-Villaseñor RM; Rojas-Castañeda JC; Landero DA
Arch Med Res; 2018 Jan; 49(1):18-26. PubMed ID: 29703608
[TBL] [Abstract][Full Text] [Related]
6. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations in toll-like receptor pathway and lung function decline in Cystic fibrosis patients.
Haerynck F; Mahachie John JM; Van Steen K; Schelstraete P; Van daele S; Loeys B; Van Thielen M; De Canck I; Nuytinck L; De Baets F
Hum Immunol; 2013 Dec; 74(12):1649-55. PubMed ID: 23994582
[TBL] [Abstract][Full Text] [Related]
8. Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.
Bremer LA; Blackman SM; Vanscoy LL; McDougal KE; Bowers A; Naughton KM; Cutler DJ; Cutting GR
Hum Mol Genet; 2008 Jul; 17(14):2228-37. PubMed ID: 18424453
[TBL] [Abstract][Full Text] [Related]
9. Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.
Faria EJ; Faria IC; Ribeiro JD; Ribeiro AF; Hessel G; Bertuzzo CS
J Bras Pneumol; 2009 Apr; 35(4):334-42. PubMed ID: 19466271
[TBL] [Abstract][Full Text] [Related]
10. Identification of SNPs in the cystic fibrosis interactome influencing pulmonary progression in cystic fibrosis.
Gisler FM; von Kanel T; Kraemer R; Schaller A; Gallati S
Eur J Hum Genet; 2013 Apr; 21(4):397-403. PubMed ID: 22892532
[TBL] [Abstract][Full Text] [Related]
11. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics.
Mekus F; Ballmann M; Bronsveld I; Bijman J; Veeze H; Tümmler B
Twin Res; 2000 Dec; 3(4):277-93. PubMed ID: 11463149
[TBL] [Abstract][Full Text] [Related]
12. A polymorphism in the 5' UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients.
Crovella S; Segat L; Amato A; Athanasakis E; Bezzerri V; Braggion C; Casciaro R; Castaldo G; Colombo C; Covone AE; De Rose V; Gagliardini R; Lanzara C; Minicucci L; Morgutti M; Nicolis E; Pardo F; Quattrucci S; Raia V; Ravazzolo R; Seia M; Stanzial V; Termini L; Zazzeron L; Cabrini G; Gasparini P
Clin Chem Lab Med; 2011 Jan; 49(1):49-54. PubMed ID: 21077791
[TBL] [Abstract][Full Text] [Related]
13. Cytokine gene polymorphisms and severity of CF lung disease.
de Vries L; Griffiths A; Armstrong D; Robinson PJ
J Cyst Fibros; 2014 Dec; 13(6):699-705. PubMed ID: 24853301
[TBL] [Abstract][Full Text] [Related]
14. Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.
McKone EF; Shao J; Frangolias DD; Keener CL; Shephard CA; Farin FM; Tonelli MR; Pare PD; Sandford AJ; Aitken ML; Kavanagh TJ
Am J Respir Crit Care Med; 2006 Aug; 174(4):415-9. PubMed ID: 16690975
[TBL] [Abstract][Full Text] [Related]
15. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Med Genet; 2014 Mar; 15():27. PubMed ID: 24593045
[TBL] [Abstract][Full Text] [Related]
17. CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severity.
Blaisdell CJ; Howard TD; Stern A; Bamford P; Bleecker ER; Stine OC
BMC Med Genet; 2004 Oct; 5():26. PubMed ID: 15507145
[TBL] [Abstract][Full Text] [Related]
18. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis.
Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD
BMC Pulm Med; 2012 Sep; 12():50. PubMed ID: 22950544
[TBL] [Abstract][Full Text] [Related]
20. Genotype and phenotype in cystic fibrosis.
Zielenski J
Respiration; 2000; 67(2):117-33. PubMed ID: 10773783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
